Costs of uncontrolled chemotherapy‐induced nausea and vomiting among working‐age cancer patients receiving highly or moderately emetogenic chemotherapy
Cancer2007Vol. 110(3), pp. 678–685
Citations Over TimeTop 10% of 2007 papers
Abstract
Despite a prevalent use of the 5-HT(3) receptor antagonists, uncontrolled CINV remained a common and costly problem among cancer patients treated with highly or moderately emetogenic chemotherapy.
Related Papers
- → Studies in postoperative sequelae. Nausea and vomiting—still a problem(1994)152 cited
- → Nausea and Vomiting in the Cancer Patient(2006)12 cited
- → A Case of Recurrent Gastric Cancer Patient Treated with Dokhwaljihwang-tnggami for Nausea and Vomitting - A Gastric Cancer Patient's Case(2013)3 cited
- → Nausea and Vomiting as the Reasons for Encounter(2011)1 cited
- The influence of nursing intervention to nausea and vomiting in chemotherapy of gastric cancer(2010)